Flonase Indirect Purchasers Sue SmithKline Beecham

Law360, New York (August 22, 2008, 12:00 AM EDT) -- Legal problems continue to stack up against SmithKline Beecham Corp., which faces another proposed class action for allegedly stalling the approval of a generic version of Flonase, the drugmaker's blockbuster nasal allergy medication.

The lawsuit, filed by Alabama-based AF Of L-AGC Building Trades Welfare Plan in the U.S. District Court for the Eastern District of Pennsylvania on Thursday, follows the filing of a similar suit by the IBEW–NECA Local 505 Health & Welfare Plan last month.

The latest proposed class action of indirect purchasers of Flonase...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.